{"id":60545,"date":"2024-12-24T22:03:11","date_gmt":"2024-12-24T21:03:11","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/ahf-injectable-prep-rollout-must-include-condom-promotion-to-combat-rising-sti-rates\/"},"modified":"2024-12-24T22:03:11","modified_gmt":"2024-12-24T21:03:11","slug":"ahf-injectable-prep-rollout-must-include-condom-promotion-to-combat-rising-sti-rates","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/ahf-injectable-prep-rollout-must-include-condom-promotion-to-combat-rising-sti-rates\/","title":{"rendered":"AHF: Injectable PrEP Rollout Must Include Condom Promotion to Combat Rising STI Rates"},"content":{"rendered":"
\n

LOS ANGELES–(BUSINESS WIRE)–#HIV<\/a>–In light of the recently announced plan<\/a> to put 2.5 million people on injectable pre-exposure prophylaxis (PrEP), specifically lenacapavir, by 2027, AIDS Healthcare Foundation (AHF<\/a>) urges global health leaders to prioritize condoms as a critical component of the rollout. While lenacapavir is a groundbreaking tool to reduce HIV transmission, promoting it without a strong emphasis on condoms ignores the alarming global rise of sexually transmitted infections, which PrEP alone cannot prevent.<\/p>\n

\n\u201cLenacapavir may be a game-changer in HIV prevention, but it\u2019s not a cure-all. Ignoring the role of condoms in the fight against STIs is a disservice to and disastrous for global public health,\u201d said AHF President Michael Weinstein. \u201cWe\u2019re already seeing record-breaking STI rates globally, with more than 374 million<\/a> new cases of STIs annually, including gonorrhea, syphilis, congenital syphilis, and chlamydia. Condoms remain the most effective and affordable way to prevent these infections while also protecting against HIV.\u201d<\/p>\n

\nDespite more than 1 million STIs acquired daily<\/a> worldwide, according to the World Health Organization, condom use is declining<\/a> in many parts of the world. In the U.S., syphilis rates rose by 74% between 2017 and 2021, and antibiotic-resistant gonorrhea strains are spreading globally. Failing to integrate condoms into PrEP campaigns exacerbates these trends, particularly in regions with limited access to STI testing and treatment. AHF calls for a comprehensive approach to sexual health that positions condoms and PrEP as complementary tools to reduce both HIV and STI rates worldwide.<\/p>\n

\nA recent study published in The Lancet<\/a> underscores the urgent need for comprehensive HIV prevention strategies. Despite a 22% decline in new HIV infections globally between 2010 and 2021, progress remains insufficient to meet the UNAIDS targets, with disparities across regions and increases in some areas. This highlights the critical role condoms play as a proven, cost-effective tool in preventing HIV transmission.<\/p>\n

\nAbout AIDS Healthcare Foundation (AHF)<\/b><\/p>\n

\nAIDS Healthcare Foundation<\/b> (AHF) is a global non-profit organization providing cutting-edge medicine and advocacy to more than 2 million people in 48 countries worldwide in Africa, the Americas, the Asia\/Pacific Region, and Europe. We are currently the largest non-profit provider of HIV\/AIDS medical care in the world. To learn more about AHF, please visit our website: www.aidshealth.org<\/a>, find us on Facebook: www.facebook.com\/aidshealth<\/a> and follow us on Twitter: @aidshealthcare<\/a> and Instagram: @aidshealthcare<\/a><\/p>\n

Contacts<\/b> <\/p>\n

\nUS MEDIA CONTACT:
\n
Ged Kenslea, <\/b>Senior Director, Communications, AHF
\n
+1 323 308 1833 work +1.323.791.5526 mobile
\n
gedk@aidshealth.org<\/a><\/p>\n

\nDenys Nazarov, <\/b>Director of Global Policy & Communications, AHF
\n
+1 323.308.1829
\n
denys.nazarov@aidshealth.org<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

LOS ANGELES–(BUSINESS WIRE)–#HIV–In light of the recently announced plan to put 2.5 million people on injectable pre-exposure prophylaxis (PrEP), specifically lenacapavir, by 2027, AIDS Healthcare Foundation (AHF) urges global health leaders to prioritize condoms as a critical component of the rollout. While lenacapavir is a groundbreaking tool to reduce HIV transmission, promoting it without a … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-60545","6":"format-standard","7":"category-industry"},"yoast_head":"\nAHF: Injectable PrEP Rollout Must Include Condom Promotion to Combat Rising STI Rates - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/ahf-injectable-prep-rollout-must-include-condom-promotion-to-combat-rising-sti-rates\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AHF: Injectable PrEP Rollout Must Include Condom Promotion to Combat Rising STI Rates - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"LOS ANGELES–(BUSINESS WIRE)–#HIV–In light of the recently announced plan to put 2.5 million people on injectable pre-exposure prophylaxis (PrEP), specifically lenacapavir, by 2027, AIDS Healthcare Foundation (AHF) urges global health leaders to prioritize condoms as a critical component of the rollout. While lenacapavir is a groundbreaking tool to reduce HIV transmission, promoting it without a ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/ahf-injectable-prep-rollout-must-include-condom-promotion-to-combat-rising-sti-rates\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2024-12-24T21:03:11+00:00\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ahf-injectable-prep-rollout-must-include-condom-promotion-to-combat-rising-sti-rates\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ahf-injectable-prep-rollout-must-include-condom-promotion-to-combat-rising-sti-rates\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"AHF: Injectable PrEP Rollout Must Include Condom Promotion to Combat Rising STI Rates\",\"datePublished\":\"2024-12-24T21:03:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ahf-injectable-prep-rollout-must-include-condom-promotion-to-combat-rising-sti-rates\\\/\"},\"wordCount\":422,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ahf-injectable-prep-rollout-must-include-condom-promotion-to-combat-rising-sti-rates\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ahf-injectable-prep-rollout-must-include-condom-promotion-to-combat-rising-sti-rates\\\/\",\"name\":\"AHF: Injectable PrEP Rollout Must Include Condom Promotion to Combat Rising STI Rates - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"datePublished\":\"2024-12-24T21:03:11+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ahf-injectable-prep-rollout-must-include-condom-promotion-to-combat-rising-sti-rates\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ahf-injectable-prep-rollout-must-include-condom-promotion-to-combat-rising-sti-rates\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ahf-injectable-prep-rollout-must-include-condom-promotion-to-combat-rising-sti-rates\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AHF: Injectable PrEP Rollout Must Include Condom Promotion to Combat Rising STI Rates\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"AHF: Injectable PrEP Rollout Must Include Condom Promotion to Combat Rising STI Rates - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/ahf-injectable-prep-rollout-must-include-condom-promotion-to-combat-rising-sti-rates\/","og_locale":"en_US","og_type":"article","og_title":"AHF: Injectable PrEP Rollout Must Include Condom Promotion to Combat Rising STI Rates - Pharma Trend","og_description":"LOS ANGELES–(BUSINESS WIRE)–#HIV–In light of the recently announced plan to put 2.5 million people on injectable pre-exposure prophylaxis (PrEP), specifically lenacapavir, by 2027, AIDS Healthcare Foundation (AHF) urges global health leaders to prioritize condoms as a critical component of the rollout. While lenacapavir is a groundbreaking tool to reduce HIV transmission, promoting it without a ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/ahf-injectable-prep-rollout-must-include-condom-promotion-to-combat-rising-sti-rates\/","og_site_name":"Pharma Trend","article_published_time":"2024-12-24T21:03:11+00:00","author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/ahf-injectable-prep-rollout-must-include-condom-promotion-to-combat-rising-sti-rates\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/ahf-injectable-prep-rollout-must-include-condom-promotion-to-combat-rising-sti-rates\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"AHF: Injectable PrEP Rollout Must Include Condom Promotion to Combat Rising STI Rates","datePublished":"2024-12-24T21:03:11+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/ahf-injectable-prep-rollout-must-include-condom-promotion-to-combat-rising-sti-rates\/"},"wordCount":422,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/ahf-injectable-prep-rollout-must-include-condom-promotion-to-combat-rising-sti-rates\/","url":"https:\/\/pharma-trend.com\/en\/ahf-injectable-prep-rollout-must-include-condom-promotion-to-combat-rising-sti-rates\/","name":"AHF: Injectable PrEP Rollout Must Include Condom Promotion to Combat Rising STI Rates - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"datePublished":"2024-12-24T21:03:11+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/ahf-injectable-prep-rollout-must-include-condom-promotion-to-combat-rising-sti-rates\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/ahf-injectable-prep-rollout-must-include-condom-promotion-to-combat-rising-sti-rates\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/ahf-injectable-prep-rollout-must-include-condom-promotion-to-combat-rising-sti-rates\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"AHF: Injectable PrEP Rollout Must Include Condom Promotion to Combat Rising STI Rates"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/60545","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=60545"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/60545\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=60545"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=60545"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=60545"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}